NasdaqGM:TVTXBiotechs
Is Travere Therapeutics (TVTX) Pricing Look Out Of Step With DCF And Sales Metrics
If you are trying to figure out whether Travere Therapeutics at around US$27.92 is attractively priced or not, you will want to see how its current value stacks up against a few different yardsticks.
The stock has returned 0.7% over the past week, while the 30 day return is a 9.6% decline and the year to date return is a 29.4% decline. This is set against a 37.1% return over the last year and 26.4% over three years.
Those mixed returns have come as investors weigh recent company specific...